A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...

The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

The approval is for Eylea to treat macular edema following retinal vein occlusion with up to every eight-week dosing after an initial dosing period. The FDA also approved a monthly dosing option for ...

Chronic wounds (CWs), like diabetic ulcers or pressure sores, are a major health care challenge, especially in the elderly.

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect ...

Menlo Park resident Carmen Caricchio is on a quest to cure childhood inherited retinal diseases, a group of rare conditions that cause the degeneration of the retina and can lead to vision impairment ...

Analysts say the two new indications should help Eylea HD as Regeneron battles for market share with Roche’s Vabysmo.

The inverted ILM flap technique yields better macular hole closure than ILM peeling for some high myopic macular holes.

Older age in adults with diabetic macular edema (DME) appears to be associated with less robust visual and anatomic gains from anti-vascular endothelial growth factor (VEGF) therapy, according to ...